Key details
Phase
Safety & dosing / Large-scale testing
Sponsor
Copenhagen University Hospital, Hvidovre
Collaborators
Bispebjerg Hospital
Enrollment target
~122 participants
Primary completion
February 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years and older
Last updated December 2025